Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Cancer overdiagnosis and overtreatment.

Klotz L.

Curr Opin Urol. 2012 May;22(3):203-9. doi: 10.1097/MOU.0b013e32835259aa. Review.

PMID:
22472510
2.

MRI and surveillance.

Ouzzane A, Puech P, Villers A.

Curr Opin Urol. 2012 May;22(3):231-6. doi: 10.1097/MOU.0b013e328351dcf7. Review.

PMID:
22388665
3.

Active surveillance: the Canadian experience.

Klotz L.

Curr Opin Urol. 2012 May;22(3):222-30. doi: 10.1097/MOU.0b013e328352598c. Review.

PMID:
22453335
4.

The Prostate cancer Research International: Active Surveillance study.

Bangma CH, Bul M, Roobol M.

Curr Opin Urol. 2012 May;22(3):216-21. doi: 10.1097/MOU.0b013e328351dcc7. Review.

PMID:
22453333
5.

Screening, early detection, and treatment of prostate cancer: a European view.

Schröder FH.

Urology. 1995 Sep;46(3 Suppl A):62-70. Review.

PMID:
7653022
6.

Psychological aspects of active surveillance.

van den Bergh RC, Korfage IJ, Bangma CH.

Curr Opin Urol. 2012 May;22(3):237-42. doi: 10.1097/MOU.0b013e328351dcb1. Review.

PMID:
22357407
7.

Formalized prediction of clinically significant prostate cancer: is it possible?

Nguyen CT, Kattan MW.

Asian J Androl. 2012 May;14(3):349-54. doi: 10.1038/aja.2011.140. Epub 2012 Feb 27. Review.

8.

Prostate cancer overdiagnosis and overtreatment.

Klotz L.

Curr Opin Endocrinol Diabetes Obes. 2013 Jun;20(3):204-9. doi: 10.1097/MED.0b013e328360332a. Review.

PMID:
23609043
9.

Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.

Zhu X, van Leeuwen PJ, Bul M, Otto SJ, de Koning HJ, Bangma CH, Schröder FH, Roobol MJ.

Eur Urol. 2011 Aug;60(2):330-6. doi: 10.1016/j.eururo.2011.05.013. Epub 2011 May 17.

PMID:
21601352
10.

The role of 5-alpha-reductase inhibitors in active surveillance.

Margel D, Fleshner N.

Curr Opin Urol. 2012 May;22(3):243-6. doi: 10.1097/MOU.0b013e328351dd57. Review.

PMID:
22472511
11.

Economic analysis of active surveillance for localized prostate cancer.

Kim S 2nd, Dall'Era MA, Evans CP.

Curr Opin Urol. 2012 May;22(3):247-53. doi: 10.1097/MOU.0b013e328351dd32. Review.

PMID:
22388666
12.

Active surveillance for prostate cancer: a review.

Klotz L.

Arch Esp Urol. 2011 Oct;64(8):806-14. Review. English, Spanish.

PMID:
22052761
13.

Overdiagnosis and overtreatment of prostate cancer.

Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R.

Eur Urol. 2014 Jun;65(6):1046-55. doi: 10.1016/j.eururo.2013.12.062. Epub 2014 Jan 9. Review.

14.

Overdiagnosis in cancer.

Welch HG, Black WC.

J Natl Cancer Inst. 2010 May 5;102(9):605-13. doi: 10.1093/jnci/djq099. Epub 2010 Apr 22. Review.

15.

Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.

Wilt TJ.

Semin Urol Oncol. 2002 Feb;20(1):10-7. Review.

PMID:
11828353
16.

Overdiagnosis and overtreatment of early detected prostate cancer.

Bangma CH, Roemeling S, Schröder FH.

World J Urol. 2007 Mar;25(1):3-9. Epub 2007 Feb 14. Review.

17.

Active surveillance in prostate cancer: patient selection and triggers for intervention.

Lees K, Durve M, Parker C.

Curr Opin Urol. 2012 May;22(3):210-5. doi: 10.1097/MOU.0b013e328351dc47. Review.

PMID:
22388664
18.

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, Feuer E, de Koning H.

J Natl Cancer Inst. 2009 Mar 18;101(6):374-83. doi: 10.1093/jnci/djp001. Epub 2009 Mar 10.

19.

Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?

Barry MJ, Mulley AJ Jr.

J Natl Cancer Inst. 2009 Mar 18;101(6):362-3. doi: 10.1093/jnci/djp028. Epub 2009 Mar 10. No abstract available.

20.

Overdiagnosis of prostate cancer.

Sandhu GS, Andriole GL.

J Natl Cancer Inst Monogr. 2012 Dec;2012(45):146-51. doi: 10.1093/jncimonographs/lgs031.

Items per page

Supplemental Content

Write to the Help Desk